Drug therapy in dyslipidemia.
Grundy
S M
SM
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001647:Bile Acids and Salts / Q000378:metabolism; D003327:Coronary Disease / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006949:Hyperlipidemias / Q000188:drug therapy*; D009525:Niacin / Q000627:therapeutic use; D011341:Probucol / Q000627:therapeutic use; D012307:Risk Factors
D000924:Anticholesteremic Agents; D001647:Bile Acids and Salts; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D009525:Niacin; D011341:Probucol